Literature DB >> 7559977

Auxotrophy of Burkholderia (Pseudomonas) cepacia from cystic fibrosis patients.

A L Barth1, T L Pitt.   

Abstract

The nutritional status of 89 isolates of Burkholderia cepacia from 81 cystic fibrosis (CF) patients was evaluated. Forty of the isolates, from 38 patients, were not able to grow in a minimal medium containing glucose and mineral salts only and were thus auxotrophs. In contrast, all of 29 isolates from non-CF (clinical and environmental) sources were prototrophic. Addition of a pool of amino acids to the minimal medium was sufficient to promote growth of all tested CF auxotrophic isolates. Indeed, phenylalanine, tyrosine, cysteine, methionine, and histidine alone or in combination were required for growth by the majority of the nutritionally deficient B. cepacia isolates. Furthermore, extracts of sputum from CF patients, when added to minimal medium, promoted growth of 29 auxotrophic B. cepacia isolates regardless of their amino acid requirements. Finally, auxotrophic and prototrophic isolates from the same patient exhibited a conserved genotype, as determined by macrorestriction analysis of chromosomal DNA. These results suggest that the auxotrophic mutants are selected from the prototrophic population and maintained by the nutritionally rich environment of the CF airways.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7559977      PMCID: PMC228364          DOI: 10.1128/jcm.33.8.2192-2194.1995

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  8 in total

1.  Two simple media for the demonstration of pyocyanin and fluorescin.

Authors:  E O KING; M K WARD; D E RANEY
Journal:  J Lab Clin Med       Date:  1954-08

2.  Response of Pseudomonas cepacia to beta-Lactam antibiotics: utilization of penicillin G as the carbon source.

Authors:  W Beckman; T G Lessie
Journal:  J Bacteriol       Date:  1979-12       Impact factor: 3.490

3.  Auxotrophy of Pseudomonas aeruginosa in cystic fibrosis.

Authors:  R F Taylor; M E Hodson; T L Pitt
Journal:  FEMS Microbiol Lett       Date:  1992-05-01       Impact factor: 2.742

4.  The identification of Pseudomonas cepacia and its occurrence in clinical material.

Authors:  B Holmes
Journal:  J Appl Bacteriol       Date:  1986-10

5.  Auxotrophic variants of Pseudomonas aeruginosa are selected from prototrophic wild-type strains in respiratory infections in patients with cystic fibrosis.

Authors:  A L Barth; T L Pitt
Journal:  J Clin Microbiol       Date:  1995-01       Impact factor: 5.948

6.  Adult cystic fibrosis: association of acute pulmonary exacerbations and increasing severity of lung disease with auxotrophic mutants of Pseudomonas aeruginosa.

Authors:  R F Taylor; M E Hodson; T L Pitt
Journal:  Thorax       Date:  1993-10       Impact factor: 9.139

7.  Utilization of human respiratory secretions by mucoid Pseudomonas aeruginosa of cystic fibrosis origin.

Authors:  D E Ohman; A M Chakrabarty
Journal:  Infect Immun       Date:  1982-08       Impact factor: 3.441

8.  Prevalence of thymidine-dependent Staphylococcus aureus in patients with cystic fibrosis.

Authors:  P H Gilligan; P A Gage; D F Welch; M J Muszynski; K R Wait
Journal:  J Clin Microbiol       Date:  1987-07       Impact factor: 5.948

  8 in total
  16 in total

1.  Phenotypic methods for determining genomovar status of the Burkholderia cepacia complex.

Authors:  D A Henry; E Mahenthiralingam; P Vandamme; T Coenye; D P Speert
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

2.  Towards "molecular Esperanto" or the Tower of Babel? (the need for harmonization of techniques for genotyping clinical isolates of Pseudomonas aeruginosa isolated from patients with cystic fibrosis).

Authors:  John E Moore; Colin E Goldsmith; J Stuart Elborn; Philip G Murphy; Peter H Gilligan; Séamus Fanning; Graham Hogg
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

3.  CcpA mediates proline auxotrophy and is required for Staphylococcus aureus pathogenesis.

Authors:  Chunling Li; Fei Sun; Hoonsik Cho; Vamshi Yelavarthi; Changmo Sohn; Chuan He; Olaf Schneewind; Taeok Bae
Journal:  J Bacteriol       Date:  2010-06-04       Impact factor: 3.490

4.  An epidemic of burkholderia cepacia transmitted between patients with and without cystic fibrosis.

Authors:  A Holmes; R Nolan; R Taylor; R Finley; M Riley; R Z Jiang; S Steinbach; R Goldstein
Journal:  J Infect Dis       Date:  1999-05       Impact factor: 5.226

5.  A fusion promoter created by a new insertion sequence, IS1490, activates transcription of 2,4,5-trichlorophenoxyacetic acid catabolic genes in Burkholderia cepacia AC1100.

Authors:  A Hübner; W Hendrickson
Journal:  J Bacteriol       Date:  1997-04       Impact factor: 3.490

6.  Comparison of isolation media for recovery of Burkholderia cepacia complex from respiratory secretions of patients with cystic fibrosis.

Authors:  D Henry; M Campbell; C McGimpsey; A Clarke; L Louden; J L Burns; M H Roe; P Vandamme; D Speert
Journal:  J Clin Microbiol       Date:  1999-04       Impact factor: 5.948

7.  Genetic analysis of Pseudomonas aeruginosa isolates from the sputa of Australian adult cystic fibrosis patients.

Authors:  Mario Anthony; Barbara Rose; Mary Beard Pegler; Mark Elkins; Helen Service; Keerthi Thamotharampillai; Jason Watson; Michael Robinson; Peter Bye; John Merlino; Colin Harbour
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

8.  Histidine auxotrophy in commensal and disease-causing nontypeable Haemophilus influenzae.

Authors:  Patricia C Juliao; Carl F Marrs; Jingping Xie; Janet R Gilsdorf
Journal:  J Bacteriol       Date:  2007-05-11       Impact factor: 3.490

9.  Growth phenotypes of Pseudomonas aeruginosa lasR mutants adapted to the airways of cystic fibrosis patients.

Authors:  David A D'Argenio; Manhong Wu; Lucas R Hoffman; Hemantha D Kulasekara; Eric Déziel; Eric E Smith; Hai Nguyen; Robert K Ernst; Theodore J Larson Freeman; David H Spencer; Mitchell Brittnacher; Hillary S Hayden; Sara Selgrade; Mikkel Klausen; David R Goodlett; Jane L Burns; Bonnie W Ramsey; Samuel I Miller
Journal:  Mol Microbiol       Date:  2007-04       Impact factor: 3.501

10.  Increased fitness of Pseudomonas fluorescens Pf0-1 leucine auxotrophs in soil.

Authors:  Wook Kim; Stuart B Levy
Journal:  Appl Environ Microbiol       Date:  2008-04-25       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.